Indiscriminate use of convalescent plasma therapy in COVID patients not advisable: ICMR

In an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the Indian Council of Medical Research (ICMR) said that a potential donor for convalescent plasma should have sufficient concentration of antibody working against COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kHpMGG
via IFTTT